Summit Trail Advisors, LLC

Position in VTRS — Viatris Inc

CIK 1698478 NEW YORK, NY

Position in VTRS

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$915,680

+$341,698 QoQ

Shares Held

67,778

+47.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Summit Trail Advisors, LLC holds $21,379,825 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HIMS	Hims & Hers Health, Inc.	581,157	$12,064,819
2	ELAN	Elanco Animal Health Inc	109,719	$2,625,575
3	ZTS	Zoetis Inc.	17,611	$2,081,796
4	VTRS	Viatris Inc This page	67,778	$915,680
5	PRGO	PERRIGO Co plc	72,968	$783,676
6	UTHR	UNITED THERAPEUTICS Corp	1,298	$769,688
7	TAK	Takeda Pharmaceutical Co Ltd	31,263	$578,990
8	NBIX	Neurocrine Biosciences Inc	3,835	$505,222

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$915,680	67,778	+47.0%	Shares	Sole	2026-05-12
2025-12-31	$573,982	46,103	+19.0%	Shares	Sole	2026-02-17
2025-09-30	$383,486	38,736	+16.1%	Shares	Sole	2025-11-14
2025-06-30	$297,815	33,350	+77.3%	Shares	Sole	2025-08-14
2025-03-31	$163,861	18,813	-36.5%	Shares	Sole	2025-04-28
2024-12-31	$369,092	29,646	+33.9%	Shares	Sole	2025-01-29
2024-09-30	$257,045	22,140	-4.2%	Shares	Sole	2024-11-12
2024-06-30	$245,786	23,122	+32.8%	Shares	Sole	2024-08-13
2024-03-31	$207,947	17,416	+13.4%	Shares	Sole	2024-04-23
2023-12-31	$166,316	15,357	-36.9%	Shares	Sole	2024-02-06
2023-09-30	$239,824	24,323	+1.3%	Shares	Sole	2023-10-30
2023-06-30	$239,719	24,020	—	Shares	Sole	2023-07-25
No filing history on record for this holder in this stock.